Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals
PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Nov 15, 2019--
PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Nov 15, 2019--